Analytical Data
-
基因名
SSX5
- Application
-
别名
Protein SSX5; SSX5; SSX5_HUMAN; Synovial sarcoma, X breakpoint 5
-
种属
Human
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O60225
-
表达区间
1-229aa
-
分子量
53.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The SSX5 protein, part of the SSX (synovial sarcoma X) family, has emerged as an intriguing subject of research due to its potential implications in cancer biology and immunotherapy. This protein is primarily expressed in synovial sarcoma, a rare but aggressive type of soft tissue cancer, making SSX5 a candidate for cancer-specific antigens. The study of SSX5 is particularly important because it is recognized by cytotoxic T lymphocytes, suggesting that it can elicit an immune response, making it a potential target for cancer vaccines or adoptive T cell therapies. Research has focused on characterizing its structure, immunogenicity, and the mechanisms by which it may contribute to tumorigenesis, providing insights into its role in malignancies beyond synovial sarcoma, including other solid tumors. Furthermore, understanding SSX5's interactions at the molecular level may pave the way for novel therapeutic strategies aimed at enhancing anti-tumor immunity. Overall, the investigation of SSX5 and its associated pathways holds promise for developing innovative treatments and improving clinical outcomes for cancer patients.
